DESIGNING OF CARCINOLYTIC ADENOVIRUS RECOMBINANT, SPECIFICALLY EXPRESSING IMMUNOMODULATORY FACTOR GM-CSF IN TUMORAL CELLS AND ITS APPLICATION Russian patent published in 2009 - IPC A61K39/235 

Abstract RU 2361611 C2

FIELD: medicine.

SUBSTANCE: invention concerns area of gene engineering, virology and medicine. Nominally replicating carcinolytic improved recombinant of the adenovirus includes the basic virus, the modified hTERT promotor and immune regulatory genes. The virus preferably expresses immunostimulating factor GM-CSF in tumoral cells. Also the modified promotor, the pharmaceutical composition including virus, the way of reception of virus and its application is revealed. The invention can be used in medicine for treatment of tumours.

EFFECT: development of a virus which preferably expresses immunostimulating factor GM-CSF in tumoral cells.

22 cl, 13 dwg, 2 tbl, 7 ex

Similar patents RU2361611C2

Title Year Author Number
GENETIC VECTOR Ad6/3-hTERT-GMCSF CONTAINING GENOMIC SEQUENCES OF RECOMBINANT ADENOVIRUS SEROTYPE 6, HUMAN TELOMERASE PROMOTER, HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE, AS WELL AS FIBER PROTEIN GENE WITH INSERTION OF FIBER KNOB DOMAIN OF ADENOVIRUS SEROTYPE 3 WITH INCREASED TRANSDUCTION INTO TUMOR CELLS 2023
  • Yudin Sergej Mikhajlovich
  • Keskinov Anton Arturovich
  • Makarov Valentin Vladimirovich
  • Fedoseeva Darya Mikhajlovna
  • Nazarov Anton Sergeevich
  • Netesov Sergej Viktorovich
  • Romanenko Margarita Vladimirovna
  • Osipov Ivan Dmitrievich
  • Vasikhovskaya Valeriya Aleksandrovna
  • Kutsejkin Sergej Sergeevich
RU2814581C1
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS 2009
  • Khemminki Akseli
  • Kanerva Anna
  • Cherullo Vinchentso
  • Pesonen Sari
RU2520823C2
ONCOLYTIC ADENOVIRUS FOR TREATING CANCER, USING IT, AND PHARMACEUTICAL COMPOSITION CONTAINING IT 2010
  • Gedan Karrio Sonija
  • Kaskal'O Pikeras Manel' Marija
  • Alemani Bonastre Ramon
RU2536931C2
EXTENDED ADOPTIVE CELL THERAPY 2014
  • Khemminki, Akseli
  • Vyakhya-Koskela, Markus
  • Tyakhtinen, Siri
  • Cherullo, Vinchentso
RU2703438C2
ADENOVIRUS WITH DIRECTED GENE EXPRESSION AND USE THEREOF 2003
  • Khol'M Per Sonne
RU2393221C2
CONDITIONALLY REPLICATING ADENOVIRUS 2012
  • Khirojyaki Mizuguchi
  • Fuminori Sakunari
RU2642293C2
ADENOVIRUS CONTAINING ALBUMIN-BINDING SITE 2015
  • Alemany Bonastre, Ramon
  • Rojas Exposito, Luis Alfonso
RU2711371C2
THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER 2016
  • Shaw, Steven
  • Westby, Michael
  • Galili, Uri
RU2720984C2
ANTICANCER COMPOSITION CONTAINING A TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND AN IMMUNE RESPONSE CONTROL POINT INHIBITOR 2018
  • Yun, Chae Ok
  • Ahn, Hyo Min
RU2740713C1
RECOMBINANT ONCOLYTIC VIRUS, METHOD FOR ITS PRODUCTION, ITS APPLICATION AND THE DRUG ON ITS BASIS 2020
  • Wu, Zetang
RU2795230C1

RU 2 361 611 C2

Authors

Ke Zunkhond

Dates

2009-07-20Published

2004-11-19Filed